Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years

Adv Exp Med Biol. 2003:528:575-8. doi: 10.1007/0-306-48382-3_117.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Behcet Syndrome / drug therapy*
  • Behcet Syndrome / physiopathology
  • Behcet Syndrome / psychology
  • Dementia / etiology
  • Disease Progression
  • Drug Monitoring
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Interleukin-6 / cerebrospinal fluid
  • Male
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Paresis / etiology
  • Time Factors
  • Wechsler Scales

Substances

  • Immunosuppressive Agents
  • Interleukin-6
  • Methotrexate